Joseph S K, Hansen C A, Williamson J R
Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia 19104.
Mol Pharmacol. 1989 Sep;36(3):391-7.
Ca2+ accumulated by rat cerebellum microsomes in the presence of MgATP was released by added inositol tetrakisphosphate [Ins(1,3,4,5)P4]. The concentrations of D-myo-inositol-1,4,5-trisphosphate [D-Ins(1,4,5)P3], D-Ins(1,3,4,5)P4, and DL-Ins(1,3,4,5)P4 required for half-maximal release were 0.15, 4.6, and 7.5 microM, respectively. Maximal concentrations of InsP4 released only 70% of the Ca2+ released by maximal concentrations of Ins(1,4,5)P3. Inositol pentakisphosphate and D-myo-inositol-1,3,4-trisphosphate were relatively inactive. Additional Ca2+ was released when Ins(1,4,5)P3 (or a nonhydrolyzable analog) was added after completion of InsP4-mediated Ca2+ release but not when this sequence of additions was reversed. This indicates that InsP4 releases Ca2+ from part of the InsP3-releasable compartment. No evidence for synergism between InsP4 and InsP3 was obtained and responses to suboptimal concentrations of both inositol phosphates were approximately additive. Heparin was a potent inhibitor of InsP4-mediated Ca2+ release. Inhibition by heparin was competitive with respect to InsP4 concentration and the Ki for heparin was 0.6 microgram/ml (approximately 100 nM), irrespective of whether InsP4 or InsP3 was used as an agonist. A 3-phosphatase capable of converting [3H]Ins(1,3,4,5)P3 to [3H]Ins(1,4,5)P3 could not be detected in cerebellum microsomes. Hence, we conclude that, in vitro, receptors capable of recognizing Ins(1,3,4,5)P4 can also be coupled directly to a Ca2+ release system.
在MgATP存在的情况下,大鼠小脑微粒体积累的Ca2+可被添加的肌醇四磷酸[Ins(1,3,4,5)P4]释放。半最大释放所需的D-肌醇-1,4,5-三磷酸[D-Ins(1,4,5)P3]、D-Ins(1,3,4,5)P4和DL-Ins(1,3,4,5)P4的浓度分别为0.15、4.6和7.5 microM。InsP4的最大浓度仅释放了最大浓度Ins(1,4,5)P3释放的Ca2+的70%。肌醇五磷酸和D-肌醇-1,3,4-三磷酸相对无活性。在InsP4介导的Ca2+释放完成后添加Ins(1,4,5)P3(或不可水解类似物)时会释放额外的Ca2+,但添加顺序颠倒时则不会。这表明InsP4从部分InsP3可释放区室释放Ca2+。未获得InsP4和InsP3之间协同作用的证据,对两种肌醇磷酸亚最佳浓度的反应大致呈加和性。肝素是InsP4介导的Ca2+释放的有效抑制剂。肝素的抑制作用在InsP4浓度方面具有竞争性作用,肝素的Ki为0.6微克/毫升(约100 nM),无论使用InsP4还是InsP3作为激动剂。在小脑微粒体中未检测到能够将[3H]Ins(1,3,4,5)P3转化为[3H]Ins(1,4,5)P3的3-磷酸酶。因此,我们得出结论,在体外,能够识别Ins(1,3,4,5)P4的受体也可直接与Ca2+释放系统偶联。